KFORCE INC (NYSE: KFRC) recorded a director transaction involving 38 shares at $0 per share on September 11, 2026.
International Stem Cell CORP (OTC: ISCO) saw a director sell 32,802 shares at $0.32 per share on September 11, 2026. The sale represented about 100.0% of that director’s prior holding, leaving no shares afterward.
Invech Holdings, Inc. (OTC: IVHI) transferred control through 88,000,000 common shares (88.0 million) and 300,000 Series A preferred shares sold to Angel Javier Perez Jimenez. The transfer was completed on August 24, 2026, after agreements dated August 10, 2026. Perez Jimenez became the controlling …
JANEL CORP director Graves Gregory B bought 395 shares at $48 to $50 per share, leaving a reported holding of 7,902 shares. The transaction matters to investors because it records a director purchase, with the acquired shares representing approximately 5% of the post-transaction holding.Key …
Jenkins George M, a director of Palvella Therapeutics, sold 27,500 shares in a series of insider transactions. The reported activity covered nine separate trades, leaving Jenkins with a recorded holding of 160,116 shares after the sales.
Karman Holdings Inc. (NYSE: KRMN) awarded Chief Financial Officer Boynton Chris Michael 11,358 shares at $0 per share. The transaction left him with 11,358 shares in the company.
KFORCE INC (NYSE: KFRC) recorded a director transaction in derivative securities equal to about 0.6% of the resulting holding. Cloudman Catherine’s resulting position stood at 10,619 derivative securities.
KFORCE INC (NYSE: KFRC) recorded a director transaction by Mehl Randall on Sep. 11, 2026, with the transaction representing about 0.8% of Randall’s resulting derivative securities holding. Randall is identified as a KFORCE INC director.
Dunwoody Ann E. reported a derivative-securities transaction involving KFORCE INC (NYSE: KFRC), with the resulting holding reported at 10,653 derivative securities. The disclosed transaction represented about 0.8% of that holding.
KFORCE INC (NYSE: KFRC) CFO Jeffrey B. Hackman reported a transaction involving 470 shares at $0 per share. The transaction was reported at $0 per share.